Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Nemolizumab for Atopic Dermatitis
Recruiting0 awardsPhase 2
Metairie, Louisiana
This trial is testing nemolizumab, a medication for severe skin conditions, in people aged 12 to 54 who haven't responded to usual treatments. It aims to see if the drug can help their immune system respond better to vaccines.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.